Eli Lilly Stock Analysis

LLY
 Stock
  

USD 371.08  7.13  1.96%   

The current rise in Eli Lilly short term price appreciation may encourage investors to take a closer look at the firm as it is trading at a share price of 371.08 on 5,556,445 in trading volume. The company directors and management have successfully maneuvered the firm at convenient times to take advantage of all market conditions in November. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.83. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Additionally, see Correlation Analysis.
  
The Eli Lilly stock analysis report makes it easy to digest most publicly released information about Eli Lilly and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Eli Lilly Stock analysis module also helps to analyze the Eli Lilly price relationship with some important fundamental indicators such as market cap and management efficiency.

Eli Lilly Stock Analysis Notes

About 85.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.21. Eli Lilly And recorded earning per share (EPS) of 6.65. The entity last dividend was issued on the 14th of November 2022. The firm had 2:1 split on the 16th of October 1997. Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. Eli Lilly operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 35000 people. To find out more about Eli Lilly And contact John Lechleiter at 317 276 2000 or learn more at https://www.lilly.com.

Eli Lilly And Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Eli Lilly's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Eli Lilly And or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Eli Lilly And has a strong financial position based on the latest SEC filings
Over 85.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Lilly and Akouos Announce Expiration of Akouos Tender Offer Eli Lilly and Company - Investors Eli Lilly and Company

Eli Lilly And Upcoming and Recent Events

Earnings reports are used by Eli Lilly to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Eli Lilly previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report3rd of February 2022
Next Financial Report26th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End3rd of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Eli Lilly Largest EPS Surprises

Earnings surprises can significantly impact Eli Lilly's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1996-10-22
1996-09-300.320.380.0618 
2015-04-23
2015-03-310.770.870.112 
2015-10-22
2015-09-300.760.890.1317 
View All Earnings Estimates

Eli Lilly SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Eli Lilly prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Eli Lilly investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Eli Lilly And specific information freely available to individual and institutional investors to make a timely investment decision.
4th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
6th of May 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
4th of May 2022
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Material Modifications to Rights of Security Holders
View
28th of April 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
14th of April 2022
Results of Operations and Financial Condition
View
11th of February 2022
Unclassified Corporate Event
View
10th of February 2022
Unclassified Corporate Event
View
9th of February 2022
Unclassified Corporate Event
View

Eli Lilly Thematic Classifications

In addition to having Eli Lilly stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Healthcare
Healthcare institutions that deliver medical services
Compulsion
Addiction driven consumer products and services
Drugs
Drug manufacturing and delivery
ESG Investing
Companies that promote environmental, social, and governance factors during their day-to-day operations

Eli Lilly Market Capitalization

The company currently falls under 'Mega-Cap' category with total capitalization of 352.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Eli Lilly's market, we take the total number of its shares issued and multiply it by Eli Lilly's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Eli Lilly Profitablity

Eli Lilly's profitability indicators refer to fundamental financial ratios that showcase Eli Lilly's ability to generate income relative to its revenue or operating costs. If, let's say, Eli Lilly is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Eli Lilly's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Eli Lilly's profitability requires more research than a typical breakdown of Eli Lilly's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.21 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.3 %, which entails that for every 100 dollars of revenue, it generated 0.0 of operating income.
Last ReportedProjected for 2022
Return on Investment 26.65  27.20 
Return on Average Assets 11.70  12.41 
Return on Average Equity 76.35  60.40 
Return on Invested Capital 0.17  0.17 
Return on Sales 0.22  0.24 

Management Efficiency

The entity has Return on Asset of 0.1148 % which means that on every $100 spent on asset, it made $0.1148 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.6659 %, implying that it generated $0.6659 on every 100 dollars invested. Eli Lilly management efficiency ratios could be used to measure how well eli lilly and manages its routine affairs as well as how well it operates its assets and liabilities. Eli Lilly Return on Investment is fairly stable at the moment as compared to the past year. Eli Lilly reported Return on Investment of 26.65 in 2021. Return on Average Assets is likely to rise to 12.41 in 2022, whereas Return on Average Equity is likely to drop 60.40 in 2022. Eli Lilly Tax Assets are fairly stable at the moment as compared to the past year. Eli Lilly reported Tax Assets of 2.49 Billion in 2021. Revenue to Assets is likely to rise to 0.65 in 2022, whereas Total Assets are likely to drop slightly above 42.2 B in 2022.
Last ReportedProjected for 2022
Book Value per Share 9.90  9.88 
Enterprise Value over EBIT 45.00  38.58 
Enterprise Value over EBITDA 36.03  29.69 
Price to Book Value 29.43  23.64 
Tangible Assets Book Value per Share 41.04  40.00 
Enterprise Value277.5 B299.4 B
Tangible Asset Value37.2 B38.4 B

Technical Drivers

As of the 1st of December, Eli Lilly shows the Coefficient Of Variation of 635.07, mean deviation of 1.37, and Downside Deviation of 1.62. In respect to fundamental indicators, the technical analysis model provides you with a way to check existing technical drivers of Eli Lilly, as well as the relationship between them. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Eli Lilly And, which can be compared to its rivals. Please confirm Eli Lilly And downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if Eli Lilly And is priced favorably, providing market reflects its regular price of 371.08 per share. Given that Eli Lilly has jensen alpha of 0.2501, we urge you to verify Eli Lilly And's prevailing market performance to make sure the company can sustain itself at a future point.

Eli Lilly And Price Movement Analysis

The output start index for this execution was one with a total number of output elements of sixty. The Moving Average is predictive technique used to analyze Eli Lilly And price data points by creating a series of averages of different subsets of Eli Lilly entire price series.
.

Eli Lilly And Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Eli Lilly insiders, such as employees or executives, is commonly permitted as long as it does not rely on Eli Lilly's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Eli Lilly insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Lilly Endowment Inc over a month ago via Macroaxis 
Sale by Lilly Endowment Inc of 400 shares of Eli Lilly
Alonzo Weems over a month ago via Macroaxis 
Bona fide gift to Alonzo Weems of 450 shares of Eli Lilly subject to Section 16
Lilly Endowment Inc over a month ago via Macroaxis 
Sale by Lilly Endowment Inc of 2100 shares of Eli Lilly
Lilly Endowment Inc over two months ago via Macroaxis 
Sale by Lilly Endowment Inc of 300 shares of Eli Lilly
Zakrowski Donald A over two months ago via Macroaxis 
Eli Lilly exotic insider transaction detected
Kimberly Johnson over three months ago via Macroaxis 
Acquisition by Kimberly Johnson of tradable shares of Eli Lilly subject to Rule 16b-3
Lilly Endowment Inc over three months ago via Macroaxis 
Sale by Lilly Endowment Inc of 1601 shares of Eli Lilly
Lilly Endowment Inc over three months ago via Macroaxis 
Sale by Lilly Endowment Inc of 720 shares of Eli Lilly
Lilly Endowment Inc over three months ago via Macroaxis 
Sale by Lilly Endowment Inc of 2428 shares of Eli Lilly
Lilly Endowment Inc over three months ago via Macroaxis 
Sale by Lilly Endowment Inc of 41857 shares of Eli Lilly
Lilly Endowment Inc over three months ago via Macroaxis 
Sale by Lilly Endowment Inc of 5263 shares of Eli Lilly
Lilly Endowment Inc over three months ago via Macroaxis 
Sale by Lilly Endowment Inc of tradable shares of Eli Lilly

Eli Lilly Outstanding Bonds

Eli Lilly issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Eli Lilly And uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Eli Lilly bonds can be classified according to their maturity, which is the date when Eli Lilly And has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Eli Lilly Predictive Daily Indicators

Eli Lilly intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Eli Lilly stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Eli Lilly Forecast Models

Eli Lilly time-series forecasting models is one of many Eli Lilly's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Eli Lilly's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Eli Lilly Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Eli Lilly prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Eli Lilly shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Eli Lilly. By using and applying Eli Lilly Stock analysis, traders can create a robust methodology for identifying Eli Lilly entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin 22.63  23.89 
EBITDA Margin 25.63  27.57 
Gross Margin 74.18  83.37 
Profit Margin 19.71  17.74 

Current Eli Lilly Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Eli Lilly analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Eli Lilly analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
299.85Buy13Odds
Eli Lilly And current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Eli Lilly analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Eli Lilly stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Eli Lilly And, talking to its executives and customers, or listening to Eli Lilly conference calls.
Eli Lilly Analyst Advice Details

Eli Lilly Stock Analysis Indicators

Eli Lilly And stock analysis indicators help investors evaluate how Eli Lilly stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Eli Lilly shares will generate the highest return on investment. By understating and applying Eli Lilly stock analysis, traders can identify Eli Lilly position entry and exit signals to maximize returns.
Begin Period Cash Flow3657100000.00
Logo U R LimglogosUSLLY.png
Common Stock Shares Outstanding911681000.00
Total Stockholder Equity8979200000.00
DescriptionEli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 7525, Humalog U-100, Humalog U-200, Humalog Mix 5050, insulin lispro, insulin lispro protamine, insulin lispro mix 7525, Hum
Total Cashflows From Investing Activities-2762300000.00
Tax Provision573800000.00
Quarterly Earnings Growth Y O Y0.32
Property Plant And Equipment Net8985100000.00
Retained Earnings8958500000.00
Cash And Short Term Investments3908600000.00
Cash3818500000.00
CodeLLY
Accounts Payable1670600000.00
Net Debt13066200000.00
50 Day M A342.2868
Total Current Liabilities15052700000.00
Currency CodeUSD
Other Operating Expenses20770300000.00
Non Current Assets Total30353600000.00
Forward Price Earnings39.5257
Non Currrent Assets Other4082700000.00
Additionally, see Correlation Analysis. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for analysis

When running Eli Lilly And price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli Lilly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.32
Market Capitalization
352.6 B
Quarterly Revenue Growth YOY
0.025
Return On Assets
0.11
Return On Equity
0.67
The market value of Eli Lilly And is measured differently than its book value, which is the value of Eli Lilly that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine Eli Lilly value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.